TGF-β control of cell proliferation

Journal of Cellular Biochemistry

Volumn 96, Issue 3, 2005, Pages 447-462

  Huang, Shuan S ^a   Huang, Jung S ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

EMT; Endocytosis; Growth inhibition; IGFBP 3; IRS; Protein phosphatase; Ratio of TGF binding to T R II and T R I; TGF ; TGF receptor signaling; Tumorigenesis

Indexed keywords

CLATHRIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INTEGRIN; PHOSPHOPROTEIN PHOSPHATASE; SCATTER FACTOR RECEPTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA RECEPTOR V; UNCLASSIFIED DRUG;

ANIMAL CELL; CARCINOGENESIS; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; ENDOCYTOSIS; ENDOTHELIUM CELL; EPITHELIUM CELL; GROWTH INHIBITION; MESENCHYME; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL PROLIFERATION; ENDOCYTOSIS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; PHOSPHOPROTEINS; PROTEIN ISOFORMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 27144554645     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20558     Document Type: Review

References (54)

1. Boylan JM, Gruppuso PA. 2002. Insulin receptor substrate-1 is present in hepatocyte nuclei from intact rats. Endocrinology 143:4178-4183.
2. Cheatham B, Kahn CR. 1995. Insulin action and the insulin signaling network. Endocr Rev 16:117-142.
3. Coppa A, Mincione G, Lazzereschi D, Ranieri A, Turco A, Lucignano B, Scarpa S, Ragano-Caracciolo M, Colletta G. 1997. Restored expression of transforming growth factor β type II receptor in k-ras-transformed thyroid cells, TGF β-resistant, reverts their malignant phenotype. J Cell Physiol 172:200-208.
4. Derynck R, Zhang YE. 2003. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425:577-584.
5. Derynck R, Akhurst RJ, Balmain A. 2001. TGF-β signaling in tumor suppression and cancer progression. Nat Genet 29:117-129.
6. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL. 2003. Distinct endocytic pathways regulate TGF-β receptor signalling and turnover. Nat Cell Biol 5:410-421.
7. Eickelberg O, Centrella M, Reiss M, Kashgarian M, Wells RG. 2002. Betaglycan inhibits TGF-β signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter βglycan function. J Biol Chem 277:823-829.
8. Firth SM, Baxter RC. 2002. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854.
9. 2- macroglobulin receptor/LRP. A growth regulatory axis. Ann NY Acad Sci 737:273-290.
10. Hayashida T, Decaestecker M, Schnaper HW. 2003. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-β-dependent responses in human mesangial cells. FASEB J 17:1576-1578.
11. Heldin CH, Miyazono K, ten Dijke P. 1997. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471.
12. Herz J, Bock HH. 2002. Lipoprotein receptors in the nervous system. Annu Rev Biochem 71:405-434.
13. Hocevar BA, Howe PH. 1998. Mechanisms of TGF-β-induced cell cycle arrest. Miner Electrolyte Metab 24: 131-135.
14. 1 action by multiple transducing pathways: Evidence for both G protein-dependent and -independent signaling. Cancer Res 49:6024-6031.
15. Huang SS, Liu Q, Johnson FE, Konish Y, Huang JS. 1997. Transforming growth factor β peptide antagonists and their conversion to partial agonists. J Biol Chem 272: 27155-27159.
16. Huang JS, Wang YH, Ling TY, Chuang SS, Johnson FE, Huang SS. 2002. Synthetic TGF-β antagonist accelerates wound healing and reduces scarring. FASEB J 16:1269-1270.
17. 1 requires LRP-1. FASEB J 17: 2068-2081.
18. Huang SS, Leal SM, Chen CL, Liu I-H, Huang JS. 2004a. Identification of insulin receptor substrate as key molecule for the TβR-V/LRP-1 mediates growth inhibition signaling cascade. FASEB J 18:1719-1721.
19. 1 involves IRS proteins. FEBS Lett 565:117-121.
20. Le Roy C, Wrana JL. 2005. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 6:112-126.
21. Leal SM, Liu Q, Huang SS, Huang JS. 1997. The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor. J Biol Chem 272:20572-20576.
22. Leal SM, Huang SS, Huang JS. 1999. Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-β receptor in mink lung epithelial cells. J Biol Chem 274:6711-6717.
23. Letamendia A, Lastres P, Botella LM, Raab U, Langa C, Velasco B, Attisano L, Bernabeu C. 1998. Role of endoglin in cellular responses to transforming growth factor-β. A comparative study with βglycan. J Biol Chem 273: 33011-33019.
24. Liu Q, Huang SS, Huang JS. 1997. Function of the type V transforming growth factor β receptor in transforming growth factor β-induced growth inhibition of mink lung epithelial cells. J Biol Chem 272:18891-18895.
25. Massague J. 1998. TGF-β signal transduction. Annu Rev Biochem 67:753-791.
26. 1 receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest 100:2182-2188.
27. Mitchell EJ, Lee K, O'Connor-McCourt MD. 1992. Characterization of transforming growth factor-β (TGF-β) receptors on BeWo choriocarcinoma cells including the identification of a novel 38-kDa TGF-β binding glycoprotein. Mol Biol Cell 3:1295-1307.
28. Mitchell H, Choudhury A, Pagano RE, Leof EB. 2004. Ligand-dependent and -independent transforming growth factor-β receptor recycling regulated by clathrin-mediated endocytosis and Rab11. Mol Biol Cell 15:4166-4178.
29. Moustakas A, Pardali K, Gaal A, Heldin CH. 2002. Mechanisms of TGF-β signaling in regulation of cell growth and differentiation. Immunol Lett 82:85-91.
30. Mulder KM. 2000. Role of Ras and Mapks in TGFβ signaling. Cytokine Growth Factor Rev 11:23-35.
31. O'Grady P, Kuo MD, Baldassare JJ, Huang SS, Huang JS. 1991a. Purification of a new type high molecular weight receptor (type V receptor) of transforming growth factor β (TGF-β) from bovine liver. Identification of the type V TGF-β receptor in cultured cells. J Biol Chem 266:8583-8589.
32. O'Grady P, Huang SS, Huang JS. 1991b. Expression of a new type high molecular weight receptor (type V receptor) of transforming growth factor β in normal and transformed cells. Biochem Biophys Res Commun 179: 378-385.
33. Pannu J, Gore-Hyer E, Yamanaka M, Smith EA, Rubinchik S, Dong JY, Jablonska S, Blaszczyk M, Trojanowska M. 2004. An increased transforming growth factor β receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor β receptor type II in scleroderma. Arthritis Rheum 50:1566-1577.
34. Petritsch C, Beug H, Baimain A, Oft M. 2000. TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest. Genes Dev 14:3093-3101.
35. Piek E, Roberts AB. 2001. Suppressor and oncogenic roles of transforming growth factor-β and its signaling pathways in tumorigenesis. Adv Cancer Res 83:1-54.
36. Quan T, He T, Kang S, Voorhees JJ, Fisher GJ. 2004. Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-β type II receptor/Smad signaling. Am J Pathol 165:741-751.
37. Razani B, Zhang XL, Bitzer M, von Gersdorff G, Bottinger EP, Lisanti MP. 2001. Caveolin-1 regulates transforming growth factor (TGF)-β/SMAD signaling through an interaction with the TGF-β type I receptor. J Biol Chem 276: 6727-6738.
38. Riser BL, Ladson-Wofford S, Sharba A, Cortes P, Drake K, Guerin CJ, Yee J, Choi ME, Segarini PR, Narins RG. 1999. TGF-β receptor expression and binding in rat mesangial cells: Modulation by glucose and cyclic mechanical strain. Kidney Int 56:428-439.
39. Roberts AB. 1998. Molecular and cell biology of TGF-β. Miner. Electrolyte Metab 24:111-119.
40. Roberts AB, Sporn MB. 1993. Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 8:1-9.
41. 1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells. J Biol Chem 280:8300-8308.
42. Sankar S, Mahooti-Brooks N, Bensen L, McCarthy TL, Centrella M, Madri JA. 1996. Modulation of transforming growth factor β receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 97:1436-1446.
43. Segarini PR. 1993. TGF-β receptors: A complicated system of multiple binding proteins. Biochim Biophys Acta 3:269-275.
44. Sharma K, McGowan TA. 2000. TGF-β in diabetic kidney disease: Role of novel signaling pathways. Cytokine Growth Factor Rev 11:115-123.
45. Sonoda I, Imoto I, Inoue J, Shibata T, Shimada Y, Chin K, Imamura M, Amagasa T, Gray JW, Hirohashi S, Inazawa J. 2004. Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma. Cancer Res 64:3741-3747.
46. Strickland DK, Gonias SL, Argraves WS. 2002. Diverse roles for the LDL receptor family. Trends Endocrinol Metab 13:66-74.
47. Sun H, Tu X, Frisco M, Wu A, Casiburi I, Baserga R. 2003. Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2. Mol Endocrinol 17:472-486.
48. 1. J Biol Chem 271:4342-4348.
49. 1-induced growth inhibition in CHO cells. FEBS Lett 562:71-78.
50. Wang J, Han W, Zborowska E, Liang J, Wang X, Willson JK, Sun L, Brattain MG. 1996. Reduced expression of transforming growth factor β type I receptor contributes to the malignancy of human colon carcinoma cells. J Biol Chem 271:17366-17371.
51. Willnow TE, Herz J. 1994. Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas exotoxin A. Evidence that this protein is required for uptake and degradation of multiple ligands. J Cell Sci 107:719-726.
52. Wu HB, Kumar A, Tsai WC, Mascarenhas D, Healey J, Rechler MM. 2000. Characterization of the inhibition of DNA synthesis in proliferating mink lung epithelial cells by insulin-like growth factor binding protein-3. J Cell Biochem 77:288-297.
53. Yamashita H, Okadome T, Franzen P, ten Dijke P, Heldin CH, Miyazono K. 1995. A rat pituitary tumor cell line (GH3) expresses type I and type II receptors and other cell surface binding protein(s) for transforming growth factor-β. J Biol Chem 270:770-774.
54. 2 subunit. Mol Biol Cell 13:4001-4012.